Why the study?
Does intracoronary 17 beta-estradiol improve coronary artery dimensions and microvascular resistance in postmenopausal women?
Does intracoronary 17 beta-estradiol improve coronary artery dimensions and microvascular resistance in postmenopausal women?
This study aimed to evaluate the short-term physiological effects of intracoronary estrogen on coronary vasomotor function in postmenopausal women, though results are not provided in the truncated abstract.
No takes yet. Share an insight, caveat, or question.
Truncated abstract yields no results; leaves open whether intracoronary estrogen improves coronary vasomotor function in postmenopausal women.
Gilligan et al. (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: